HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MUTYH association with esophageal adenocarcinoma in a Han Chinese population.

Abstract
Adenocarcinoma of esophagus (AE) is a complex disease, affected by a variety of genetic and environmental factors. Much evidence has shown that the MutY glycosylase homologue (MUTYH) plays a key role in the pathogenesis of many cancers. However, there have been no reports on influence on AE in the Han Chinese population. The objective of this study was to investigate this issue. A gene-based association study was conducted using three single nucleotide polymorphisms(SNPs) reported in previous studies. The three SNPs (rs3219463, rs3219472, rs3219489) were genotyped in 207 unrelated AE patients and 249 healthy controls in a case-control study using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). The results revealed that the genotype distribution of rs3219472 differed between the case and control groups (OR=1.66,95%CI=1.11-2.48, P=0.012 ), indicating that an association may exist between MUTYH and AE. These findings support a signifcant role for MUTYH in AE pathogenesis in the Han Chinese population.
AuthorsFeng Kong, Xue-Ying Han, Yun Luan, Tong-Gang Qi, Chao Sun, Jue Wang, Hua-Ying Hou, Yu-Hua Jiang, Jing-Jie Zhao, Guang-Hui Cheng
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 14 Issue 11 Pg. 6411-3 ( 2013) ISSN: 2476-762X [Electronic] Thailand
PMID24377542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Glycosylases
  • mutY adenine glycosylase
Topics
  • Adenocarcinoma (epidemiology, genetics)
  • Asian People (genetics)
  • Case-Control Studies
  • China (epidemiology)
  • DNA Glycosylases (genetics)
  • Esophageal Neoplasms (epidemiology, genetics)
  • Female
  • Genetic Association Studies (methods)
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: